Studying the potential ameliorative effect of biosynthesized selenium nanoparticles using epigallocatechin gallate against depression in rats
Introduction: Major depressive disorder (MDD) is a complex neuropsychiatric disorder with multifactorial origins involving oxidative stress, neuroinflammation, neurotransmitter imbalance, and HPA axis dysfunction. Conventional treatments are often limited by side effects and suboptimal efficacy, confirming the need for alternative therapies. This study investigates the antidepressant-like and neuroprotective potential of selenium nanoparticles biosynthesized using epigallocatechin gallate (SeNPs
Record details
Published: 13 January 2026
Source: OpenAlex
Category: Research
Topics: Finance, VC & PE
Retrieved: 14 July 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
Bridging technology and sustainability: examining the role of green AI adoption in Indian banking sector
OpenAlex · 12 January 2026
Human-Centric Artificial Intelligence Pedagogy (HCAP) framework developed from TPACK through integration of artificial intelligence literacy and competency
OpenAlex · 15 January 2026
Ze System Manifesto
OpenAlex · 9 January 2026
An investigation of the relationship between grit, physical activity, and self-efficacy: a variable-centered and person-centered approach
OpenAlex · 6 January 2026
Bone turnover markers (β-CTX, PINP, ALP) in osteoporosis: correlation with bone loss and fracture risk stratification
OpenAlex · 5 January 2026
Exploring the role of agentic AI in fostering self-efficacy, autonomy support, and self-learning motivation in higher education
OpenAlex · 22 January 2026
How to cite this record
ethics.ai (13 January 2026), “Studying the potential ameliorative effect of biosynthesized selenium nanoparticles using epigallocatechin gallate against depression in rats,” evidence record 10031, https://ethics.ai/record/10031 (originally published by OpenAlex).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.